Humana Inc. announced on March 3 2026 that it has entered into new value‑based cardiology care agreements with Karoo Health, US Heart and Vascular, and Chamber Cardio, building on its existing partnership with CVAUSA’s Novocardia Care Solutions. The agreements extend Humana’s integrated care model to more Medicare Advantage members, enabling coordinated, evidence‑based cardiac services through a network of participating cardiologists.
The new contracts cover a broad geographic footprint, adding cardiology specialists in key states where Humana’s Medicare Advantage plans have a strong presence. By integrating these providers into its CenterWell delivery system, Humana can deliver a seamless continuum of care—from primary and home health to specialty cardiology—while aligning incentives for quality and cost control.
Humana’s leadership frames the expansion as a strategic lever to improve heart‑health outcomes and reduce hospitalizations, which in turn supports margin improvement and member retention. The company’s 3‑year revenue growth of 13.7% and a net margin of 0.92% illustrate the pressure to enhance value‑based care as a means to offset cost inflation and competitive pricing in the Medicare Advantage market.
Caraline Coats, Senior Vice President of Clinical Strategy, said, “Managing a heart condition can feel overwhelming. Our members need integrated, coordinated, evidence‑based care that meets them where they are.” She added, “As a leader in value‑based care, Humana is committed to expanding access to high‑quality, whole‑person care that supports better health outcomes.”
The partnership expansion strengthens Humana’s competitive position in the Medicare Advantage market by broadening its specialty care network, potentially lowering readmission rates and improving member health metrics. By embedding cardiology services within its CenterWell integrated delivery system, Humana can better align provider incentives with member outcomes, a key driver of cost containment and quality improvement in value‑based models.
The move signals Humana’s continued commitment to scaling its value‑based care strategy, reinforcing its focus on whole‑person health and positioning the company to capture growth in the high‑margin Medicare Advantage segment.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.